Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.

Source:http://linkedlifedata.com/resource/pubmed/id/12941844

Cancer Res. 2003 Aug 15 63 16 5126-35

Download in:

View as

General Info

PMID
12941844